Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Feasibility of Treatment for Vaping Cessation

Trial Profile

The Feasibility of Treatment for Vaping Cessation

Status: Withdrawn prior to enrolment
Phase of Trial: Phase 0

Latest Information Update: 10 Feb 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Varenicline (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Acronyms VAPEscape

Most Recent Events

  • 06 Feb 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.
  • 09 Jun 2022 Planned initiation date changed from 1 May 2022 to 1 May 2023.
  • 05 Oct 2021 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top